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INTRODUCTION
Gilbert's syndrome is a common cause of benign hyper-
bilirubinemia in the general population. It was first described
by Augustin Nicolas Gilbert and co-workers in 1900 (1).
Clinically manifest Gilbert's syndrome with a stable
elevated serum unconjugated hyperbilirubinemia, or with
unconjugated hyperbilirubinemia after a 24-h fast, occurs
with a frequency varying between 2% and 12% (2-6).
Although there are various possible causes of hyper-
bilirubinemia after liver transplantation, for example, during
episodes of rejection, cholestasis, cholangitis or hemolysis,
Gilbert's syndrome should be considered an additional
potential cause. However, in case of liver transplantation
from a cadaveric body, it is impossible to diagnose the
donor as Gilbert's syndrome. We have not been able to
identify any report in which donor was diagnosed as
Gilbert's syndrome before liver trnasplantation. We only
found reports in which the donor was suspected as Gilbert's
syndrome after diagnosis as Gilbert's syndrome for a
recipient after cadaveric liver transplantation (7-10). There
is no information on whether a liver with Gilbert's syndrome
can be used as a graft of living-related liver transplan-
tation. We describe the clinical course of an adult patient
who underwent living-related liver transplantation (LRLT)
from a donor who was diagnosed as Gilbert's syndrome
before operation.
CASE REPORT
Donor : The patient's 57-year-old father was the candidate
for LRLT. Although histological findings in the preoperative
liver biopsy specimens showed slight fatty infiltration, his
efforts to reduce caloric intake resulted in successful
improvement fatty infiltration of the liver within 6 months.
Preoperative his hepatic function was normal except
for hyperbilirubinemia. Laboratory data showed alanine
aminotransferase(ALT) 10 international units(IU)/L (normal,
3-30IU/L), aspartate aminotransferase(AST) 12IU/L (normal,
10-30 IU/L), alkaline phosphatase(ALP) 147 IU/L (normal,
81-231 IU/L), lactic dehydrogenase(LDH) 270 IU/L (normal,
237-454 IU/L), γ-glutamyl transpeptidase(γ-GTP) 37 IU/L
(normal, 7-22 IU/L), cholinesterase 349 IU/L (normal, 200-
460 IU/L), total bilirubin 2.3 mg/dl (normal, 0.1-1.0 mg/
dl), conjugated bilirubin 0.3 mg/dl (normal, 0-0.4 mg/dl),
total protein 6.7g/dl (normal, 6.3-8.2g/dl) and serum
albumin 4.0 g/dl (normal, 3.5-5.1 g/dl). He was diagnosed
as Gilbert's syndrome because of an increase of unconjugated
serum bilirubin during low caloric intake (Fig.1) and
nicotinic acid test (Fig.2). The standard liver volume for
the patient was calculated to be 900 ml on the basis of
body weight. Volumetric analysis with computed tomography
revealed that the left lobe volume of the donor's liver was
512 ml, corresponding to 56% of the recipient standard
liver volume.
Recipient : A 22-year-old woman had been diagnosed as
having liver cirrhosis at the age of 5. She had undergone
devascularization and transection of the esophagus, and
splenectomy for esophageal varices at the age of 8.
Complications such as spontaneous bacterial peritonitis
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and nonspecific colitis sometimes appeared from 17 years
old, and icterus and ascites had appeared on all such
occasions. These complications frequently occured from
22 years old. Laboratory data before liver transplantation
showed ALT 129 IU/L (normal, 3-30 IU/L), AST 141 IU/L
(normal, 10-30 IU/L), ALP 1316 IU/L (normal, 81-231 IU/
L), LDH 457 IU/L (normal, 237-454 IU/L), γ-GTP 446 IU/
L (normal, 7-22 IU/L), cholinesterase 137 IU/L (normal,
200-460IU/L), total bilirubin 6.5mg/dl (normal, 0.1-1.0mg/
dl), conjugated bilirubin 4.2 mg/dl (normal, 0-0.4 mg/dl),
total protein 8.0 g/dl (normal, 6.3-8.2 g/dl) and serum
albumin 2.8 g/dl (normal, 3.5-5.1 g/dl).
The patient and her family members were informed that
LRLT might be possible, and they indicated that the
patient's 57-year-old father was willing to act as the donor.
This proporsal was submitted to the ethical committee of
The University of Tokushima, School of Medicine and was
accepted.
On March 28 th, 1995, the patient underwent LRLT with
the donor's left lobe as the graft. The graft weight was
440g and the graft corresponded to 49% of the recipient's
standard liver volume. Volumetric analysis showed rapid
enlargement of graft to 683ml as early as one week after
the operation. Although the recipient had acute rejection
and stenosis of hepaticojejunostomy within 6months,
unconjugated bilirubin-dominant hyperbilirubineia never
appeared. The recipient was well until 11 months after
surgery. Changes of ALP, ALT, AST and bilirubin in the
recipient within 4 weeks after operation are shown in
Figures 3 and 4. Although she suffered from acute hepatitis
due to Hepatitis B virus and died of subacute fulminant
hepatitis 16 months after liver transplantation, the recipient
had kept good liver function up to 1 year. Postoperative
course of the donor was uneventful and he returned to
work after dischraging from the hospital.
DISCUSSION
Estimates of the prevalence of Gilbert's syndrome range
from 3% to 7% in the general population, and up to 12% in
the male population (11, 12). Gilbert's syndrome can be
transferred from the donor to a recipient. The reason why
it seems that the prevalence of Gilbert's syndrome in the
post liver-transplant population is significantly lower than
in the general population is that in case of cadaveric liver
transplantation, an unexplained hyperbilirubinemia in a
potential donor may cause the transplant team to reject a
potential donor (10). Furthermore, because brain death
donors at the time of organ donation usually are on
ventilators and have many complications in intensive care
Fig.1. Low caloric intake test : Bilirubin levels after 3 days under
400 kcal diet. Total bilirubin levels increased within 72 hours up to
2.8 mg/dl due to increase of unconjugated bilirubin.
Fig.２. Nicotinic acid test : IV administration of 50mg nicotinic acid.
Unconjugated bilirubin levels increased within 2 hours up to 2.2 mg/
dl due to increase of unconjugated bilirubin.
Fig.3. Changes of ALP, ALT and AST : Alkaline phosphatase (ALP),
alanine aminotransferas(ALT) and aspartate aminotransferase(AST)
levels in serum gradually decreased, but not within normal range in
1 month after LRLT.
Fig.4. Changes of bilirubin : Bilirubin levels in serum decreased
after LRLT and unconjugated hyperbilirubinemia never appeared.
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units, it is very difficult for the transplant team to diagnose
donors as Gilbert's syndrome.
In case of cadaveric liver transplantation, the diagnosis
that the donor was Gilbert's syndrome is only speculation
from the fact that the recipient was diagnosed as Gilbert's
syndrome after liver transplantation. However, in case of
LRLT, the donor can be diagnosed as Gilbert's syndrome
before the operation from an increase in unconjugated
bilirubin levels during low caloric intake and nicotinic acid
test. But now, it is not clear whether the liver with Gilbert's
syndrome can be used as a graft or not. Gates reported
that those recipients who did seem to have Gilbert's syn-
drome had excellent long term survival and completely
normal graft function by analysis of 3 patients with Gilbert's
syndrome out of their 229 post-transplant patients (10). How-
ever, a report in which one case whose total and conjugated
bilirubin levels were 1.5 and 0.6 mg/dl, respectively, was
diagnosed as having Gilbert's syndrome, which eliminated
him as a candidate (13). They also mentioned that in
accordance with their policy to make every effort to avoid
any possible postoperative increase in serum bilirubin level,
even though the other liver function tests for the donor
candidate were completely normal, they were compelled
to pass over the primary candidate for the secondary one
(13). However, they are changing their opinion to relaxing
their guidelines for donor selection, because slight elevation
of serum bilirubin poses little direct hazard to the
living-related liver transplantation from their experiences.
In our case, if possible, we selected the patient's mother
instead of the father as a donor. But the mother could not
be a donor because she sufferred from primary biliary
cirrhosis. We think that intermittent hyperbilirubinemia
caused by Gilbert's syndrome in the recipient does not
lead to poor outcome of LRLT because patients with
Gilbert's syndrome have no damage in the liver, as in our
patient's donor. Furthermore, hyperbilirubinemia due to
Gilbert's syndrome does not always appear in the recipient,
as in our case.
In a recent study, it was shown that patients with Gilbert's
syndrome had an A(TA)7 TAA instead of an A(TA)6 TAA
sequence in the bilirubin UDP-glucuronosyltransferase-gene
promotor region on both alleles. It is possible that a liver
from a donor with the A(TA)7TAA/A(TA)7TAA genotype
causes clinically manifest Gilbert's syndrome in the recipient
(14). Jansen also mentioned that a liver with Gilbert's
syndrome genotype usually has few consequences for the
recipient and an isolated unconjugated bilirubin serum
level in the donor is no reason not to use that liver for
organ donation (14). Although, in our case, the donor was
diagnosed as Gilbert's syndrome by both 3-day low caloric
test and nicotinic acid test, our recipient did not clinically
manifest Gilbert's syndrome, probably because the expression
of Gilbert's syndrome is influenced by food intake, cigarette
smoking, alcohol consumption, medication and the fat
content of the diet in addition to the promotor region
abnormality.
We conclude that the liver with Gilbert's syndrome can
be used as a graft of living-related liver transplantation.
However, it is very important for the transplant surgeons to
be aware that Gilbert's syndrome can be transferred from
the donor to a recipient because unexplained post-transplant
hyperbilirubinemia causes confusion and gives a compli-
cated evaluation to the recipient.
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